Insider Trading & Ownership - Boyle Scott N

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Boyle Scott N

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-07
Tax Withholding
2024-11-12
4:17 pm
N/A
N/A
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
1,102$6.0467,067
(Direct)
View
2024-11-07
Exercise
2024-11-12
4:17 pm
N/A
2025-02-28
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
3,750$067,067
(Direct)
View
2024-09-16
Tax Withholding
2024-09-17
5:12 pm
N/A
N/A
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
661$6.3668,169
(Direct)
View
2024-09-16
Exercise
2024-09-17
5:12 pm
N/A
2025-02-28
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
2,250$068,169
(Direct)
View
2024-03-07
Option Award
2024-03-08
7:28 pm
N/A
2032-01-02
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
115,000$0115,000
(Direct)
View
2024-03-07
Disposition
2024-03-08
7:28 pm
N/A
2032-01-02
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
115,000$0115,000
(Direct)
View
2024-02-14
Option Award
2024-02-15
5:03 pm
N/A
2034-02-13
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
150,100$0175,130
(Direct)
View
2024-02-13
Tax Withholding
2024-02-15
5:03 pm
N/A
N/A
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
1,735$6.53175,130
(Direct)
View
2023-09-18
Option Award
2023-09-19
7:23 pm
N/A
2033-09-17
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
120,000$0120,000
(Direct)
View
2023-08-30
Tax Withholding
2023-08-31
4:09 pm
N/A
N/A
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
661$2.9343,265
(Direct)
View
2023-08-30
Exercise
2023-08-31
4:09 pm
N/A
2025-02-28
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
2,250$043,265
(Direct)
View
2023-02-13
Option Award
2023-02-15
4:45 pm
N/A
2033-02-12
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
110,000$0115,176
(Direct)
View
2023-01-30
Exercise
2023-02-01
4:10 pm
N/A
2025-02-28
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
3,750$023,926
(Direct)
View
2023-01-30
Tax Withholding
2023-02-01
4:10 pm
N/A
N/A
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
1,222$7.7823,926
(Direct)
View
2022-05-26
Tax Withholding(A)
2022-06-14
4:45 pm
N/A
N/A
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
1,102$7.012,648
(Direct)
View
2022-05-25
Exercise
2022-05-27
4:15 pm
N/A
2025-02-28
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
3,750$026,250
(Direct)
View

Ownership
2022-03-17
4:18 pm
N/A
2032-01-02
C4 Therapeutics Inc.CCCCBoyle Scott N
Chief Business Officer
0$0141,250
(Direct)
View
(A) Indicate amendment filing.